Joseph I Shapiro Selected Research

Non-alcoholic Fatty Liver Disease

1/2018	Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease.
10/2017	Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis.
1/2015	Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph I Shapiro Research Topics

Disease

32	Fibrosis (Cirrhosis) 01/2020 - 08/2002
26	Obesity 05/2022 - 01/2013
21	Cardiomyopathies (Cardiomyopathy) 01/2022 - 09/2005
21	Hypertension (High Blood Pressure) 07/2019 - 01/2003
15	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 02/2002
13	Heart Failure 12/2021 - 08/2002
12	Renal Insufficiency (Renal Failure) 01/2022 - 05/2003
10	Chronic Renal Insufficiency 01/2021 - 07/2006
10	Cardiomegaly (Heart Hypertrophy) 02/2020 - 01/2003
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2019 - 01/2015
9	Renal Artery Obstruction (Renal Artery Stenosis) 01/2019 - 10/2006
8	Insulin Resistance 01/2021 - 03/2012
8	Inflammation (Inflammations) 12/2020 - 01/2013
8	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 01/2016
6	Anemia 01/2022 - 02/2002
5	Hyponatremia 01/2021 - 08/2007
4	Atherosclerosis 05/2022 - 09/2011
4	COVID-19 01/2022 - 07/2020
4	Kidney Diseases (Kidney Disease) 12/2021 - 05/2006
4	Proteinuria 01/2020 - 04/2014
4	Myocardial Infarction 01/2018 - 11/2010
4	Pathologic Constriction (Stenosis) 12/2015 - 11/2003
3	Neoplasms (Cancer) 07/2022 - 09/2011
3	Fatty Liver 05/2022 - 01/2015
3	Hypertrophy 01/2020 - 09/2005
3	Stroke (Strokes) 01/2020 - 01/2014
3	Non-alcoholic Fatty Liver Disease 01/2018 - 01/2015
3	Albuminuria 09/2017 - 01/2016
3	Body Weight (Weight, Body) 10/2015 - 05/2003
3	Pre-Eclampsia (Preeclampsia) 02/2012 - 07/2008
2	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 11/2020
2	Infections 01/2022 - 11/2020
2	Hypernatremia 07/2018 - 01/2017
2	Disease Progression 01/2017 - 01/2016
2	Alcoholic Fatty Liver 02/2016 - 01/2015
2	Isolated Systolic Hypertension 01/2016 - 01/2014
2	Ischemia 01/2013 - 11/2010
2	Leukemia 06/2012 - 05/2009
1	Carcinogenesis 07/2022

Drug/Important Bio-Agent (IBA)

41	Adenosine Triphosphatases (ATPase)IBA 07/2022 - 01/2003
19	Oxidants (Oxidizing Agents)IBA 05/2022 - 09/2005
18	Cardiac GlycosidesIBA 01/2019 - 03/2006
15	SodiumIBA 12/2021 - 12/2002
15	marinobufageninIBA 10/2018 - 12/2002
11	pNaKtideIBA 05/2022 - 09/2011
10	Peptides (Polypeptides)IBA 07/2022 - 09/2011
10	SaltsIBA 07/2019 - 12/2010
9	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
8	CytokinesIBA 01/2022 - 01/2016
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 05/2003
8	CreatinineIBA 01/2019 - 11/2003
7	CollagenIBA 01/2020 - 01/2007
6	AntioxidantsIBA 11/2020 - 01/2016
6	AdiponectinIBA 01/2020 - 01/2012
5	NaKtideIBA 11/2021 - 01/2019
5	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 01/2018 - 01/2003
5	Hormones (Hormone)IBA 12/2010 - 07/2008
4	AdipokinesIBA 01/2020 - 01/2016
4	Cystatin CIBA 01/2019 - 10/2011
4	PotassiumIBA 07/2018 - 09/2005
4	MicroRNAs (MicroRNA)IBA 01/2018 - 03/2016
4	Transcription Factors (Transcription Factor)IBA 06/2012 - 05/2009
3	Erythropoietin FDA Link 01/2022 - 02/2002
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2017
3	oxidized low density lipoproteinIBA 08/2020 - 01/2016
3	EnzymesIBA 07/2020 - 03/2013
3	LipidsIBA 01/2020 - 01/2015
3	LeptinIBA 01/2019 - 01/2016
3	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 01/2014
3	Monoclonal AntibodiesIBA 04/2014 - 04/2011
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2013 - 08/2002
3	bufadienolideIBA 06/2012 - 04/2011
2	Retinaldehyde (Retinal)IBA 12/2020 - 04/2016
2	Heme Oxygenase-1IBA 11/2020 - 10/2016
2	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2019 - 01/2017
2	HDL CholesterolIBA 11/2017 - 01/2016
2	AcidsIBA 08/2017 - 01/2015
2	Blood Glucose (Blood Sugar)IBA 08/2017 - 01/2012
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 08/2017 - 03/2013
2	SmokeIBA 01/2017 - 12/2016
2	AlbuminsIBA 11/2016 - 09/2004
2	LigandsIBA 03/2016 - 01/2013
2	Uric Acid (Urate)IBA 01/2016 - 01/2016
2	FructoseIBA 01/2015 - 01/2014
2	Vasopressins (Vasopressin)IBA 11/2014 - 08/2007
2	digoxin antibodies Fab fragments (Fabad)IBA 04/2014 - 06/2012
2	CD40 Ligand (CD40L)IBA 04/2013 - 09/2011
2	Mineralocorticoid Receptor AntagonistsIBA 01/2013 - 08/2002
2	Digoxin (Digitek)FDA LinkGeneric 06/2012 - 07/2008
2	Phenobarbital (Luminal)FDA Link 10/2011 - 07/2010
1	SurvivinIBA 07/2022
1	Apoptosis Regulatory ProteinsIBA 07/2022
1	Annexin A5IBA 01/2022

Therapy/Procedure

17	Therapeutics 07/2022 - 07/2006
16	Nephrectomy 01/2022 - 01/2003
5	Stents 11/2016 - 11/2003
3	Ligation 11/2017 - 09/2004
2	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2016 - 01/2014